G B John Mancini Selected Research

G B John Mancini Research Topics

Disease

34	Cardiovascular Diseases (Cardiovascular Disease) 03/2024 - 10/2002
28	Coronary Artery Disease (Coronary Atherosclerosis) 11/2021 - 06/2006
24	Myocardial Infarction 02/2024 - 06/2006
14	Coronary Disease (Coronary Heart Disease) 04/2024 - 06/2006
14	Dyslipidemias (Dyslipidemia) 03/2024 - 06/2006
14	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2024 - 01/2018
14	Myocardial Ischemia (Ischemic Heart Diseases) 01/2023 - 07/2003
9	Ischemia 04/2024 - 03/2008
9	Atherosclerosis 11/2021 - 09/2006
8	Chronic Renal Insufficiency 01/2022 - 12/2009
7	Hypertension (High Blood Pressure) 01/2023 - 06/2006
7	Acute Coronary Syndrome 11/2021 - 07/2003
7	Infarction (Infarctions) 06/2010 - 11/2005
6	Thrombosis (Thrombus) 02/2024 - 05/2006
6	Type 2 Diabetes Mellitus (MODY) 01/2024 - 11/2020
5	Pathologic Constriction (Stenosis) 04/2024 - 07/2009
5	ST Elevation Myocardial Infarction 02/2024 - 01/2008
5	Heart Failure 01/2024 - 01/2010
5	Stroke (Strokes) 01/2024 - 07/2009
5	Hypercholesterolemia 05/2022 - 10/2018
4	Hyperlipidemias (Hyperlipidemia) 12/2023 - 10/2008
4	Chronic Obstructive Pulmonary Disease (COPD) 12/2023 - 05/2005
4	Atherosclerotic Plaque (Atheroma) 10/2023 - 12/2012
4	Inflammation (Inflammations) 11/2021 - 06/2002
4	Myalgia 09/2020 - 01/2018
3	Muscular Diseases (Myopathy) 06/2023 - 01/2016
3	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 06/2023 - 01/2018
3	Hypotension (Low Blood Pressure) 01/2019 - 09/2009
3	Hemorrhage 01/2016 - 11/2005
2	Unstable Angina 12/2022 - 01/2019
2	Non-ST Elevated Myocardial Infarction 12/2022 - 01/2016
2	Familial Combined Hyperlipidemia (Combined Hyperlipidemia, Familial) 01/2022 - 11/2021
2	Abdominal Aortic Aneurysm 01/2021 - 11/2016
2	Diabetes Mellitus 11/2020 - 01/2019
2	Gout 10/2020 - 09/2020
2	Vascular Diseases (Vascular Disease) 03/2020 - 11/2013
2	Atrial Fibrillation 01/2018 - 08/2015
2	Xanthomatosis (Xanthoma) 01/2018 - 01/2018
2	Cataract (Cataracts) 01/2016 - 12/2014
2	Stable Angina 09/2013 - 03/2011
2	Lung Injury 06/2005 - 05/2005
1	COVID-19 02/2024
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2024
1	Homozygous Familial Hypercholesterolemia 01/2024
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 01/2024

Drug/Important Bio-Agent (IBA)

29	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2024 - 07/2003
19	LDL CholesterolIBA 04/2024 - 06/2014
19	oxidized low density lipoproteinIBA 01/2024 - 03/2016
17	LipidsIBA 03/2024 - 09/2006
10	CholesterolIBA 11/2021 - 06/2002
8	omega-Chloroacetophenone (Mace)IBA 01/2024 - 01/2008
8	8- hydroxy- 2,2,14,14- tetramethylpentadecanedioic acidIBA 01/2024 - 10/2018
4	Triglycerides (Triacylglycerol)IBA 01/2022 - 04/2012
4	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 07/2011
4	HDL CholesterolIBA 01/2021 - 07/2011
4	CalciumIBA 06/2014 - 09/2010
3	Lipoprotein(a)IBA 03/2024 - 01/2020
3	Angiotensin Receptor AntagonistsIBA 12/2023 - 06/2006
3	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2022 - 01/2021
3	lipoprotein cholesterolIBA 01/2019 - 09/2009
3	Apolipoproteins B (ApoB)IBA 01/2019 - 01/2018
3	Ezetimibe (Zetia)FDA Link 10/2018 - 01/2018
2	evolocumabIBA 12/2023 - 06/2022
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2023 - 06/2006
2	C-Reactive ProteinIBA 01/2023 - 08/2003
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022 - 01/2021
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 05/2015
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2022 - 06/2006
2	SodiumIBA 01/2022 - 01/2021
2	Sodium-Glucose Transport ProteinsIBA 01/2022 - 01/2022
2	ApolipoproteinsIBA 11/2021 - 12/2012
2	Interleukin-6 (Interleukin 6)IBA 11/2021 - 01/2016
2	Insulin (Novolin)FDA Link 10/2021 - 03/2012
2	AnticoagulantsIBA 01/2018 - 08/2015
2	Lipoproteins (Lipoprotein)IBA 01/2018 - 10/2008
2	TroponinIBA 01/2016 - 07/2014
2	Biomarkers (Surrogate Marker)IBA 01/2016 - 06/2004
2	Anti-Bacterial Agents (Antibiotics)IBA 06/2005 - 05/2005
2	Angiotensin II Type 1 Receptor BlockersIBA 06/2005 - 12/2002
1	CanagliflozinIBA 01/2024
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2024
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 12/2023
1	Neprilysin (Neutral Endopeptidase)IBA 12/2023
1	Mineralocorticoid Receptor AntagonistsIBA 12/2023
1	Dihydrotachysterol (AT 10)IBA 06/2023
1	MetalsIBA 01/2023
1	Proprotein Convertase 9IBA 06/2022
1	SymportersIBA 01/2022
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022

Therapy/Procedure

72	Therapeutics 04/2024 - 12/2002
38	Percutaneous Coronary Intervention 02/2024 - 05/2006
10	Stents 02/2024 - 06/2006
5	Secondary Prevention 06/2023 - 03/2010
4	Conservative Treatment 04/2024 - 10/2014
4	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 11/2020 - 07/2009
4	Myocardial Revascularization 01/2019 - 11/2005
2	Drug-Eluting Stents 01/2023 - 04/2013
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2020
2	Transcatheter Aortic Valve Replacement 01/2018 - 05/2012
2	Thrombectomy 01/2008 - 05/2006